Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
Article in Frontiers in Oncology (November 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (November 2022)
Article in Current Oncology Reports (February 2021)
Article in Cancer Immunology Research (December 2019)